Abstract
Delirium is commonly encountered in the hospital setting, particularly in the intensive care unit. However, the diagnosis is often missed, due in part to the nature of the illness, fluctuating levels of consciousness, and varied presentation. Even when it is recognized, delirium can be hard to manage, with multiple factors contributing to its course. In this article, we review the latest information regarding the underlying mechanisms of the syndrome and treatment options available. This is accomplished by examining two complex cases encountered at a university medical center-based psychosomatic service.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Adamis D, Treloar A, Martin F, Macdonald A: A brief review of the history of delirium as a mental disorder. History Psychiatry 2007, 18:459–469.
Maldonado JR: Delirium in the acute care setting: characteristics, diagnosis, and treatment. Crit Care Clin 2008, 24:657–722.
Lewis M, Barnett S: Postoperative delirium: the tryptophan dysregulation model. Med Hypotheses 2004, 63:402–406.
Pae C, Marks D, Han C, et al.: Delirium: where do we stand? Curr Psychiatry Rep 2008, 10:240–248.
Pandharipande P, Cotton BA, Shintani A, et al.: Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008, 65:34–41.
Inouye SK: Current concepts: delirium in older persons. N Engl J Med 2006, 354:1157–1165.
Bourne R, Tahir T, Borthwick M, Sampson E: Drug treatment of delirium: past, present, and future. J Psychosom Res 2008, 65:273–282.
Mukadam N, Ritchie CW, Sampson EL: Cholinesterase inhibitors for delirium: what is the evidence? Int Psychogeriatr 2008, 20:209–218.
Van Der Mast R: Delirium: the underlying pathophysiological mechanisms and the need for clinical research. J Psychosom Res 1996, 41:109–113.
Maldonado J: Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidenced-based approach to prevention and treatment. Crit Care Clin 2008, 24:789–856.
Gaudreau J, Gagnon P: Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 2005, 64:471–475.
Pandharipande P, Pun B, Herr D, et al.: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients. JAMA 2007, 298:2644–2653.
Shigeta H, Yasui A, Nimura Y, et al.: Postoperative delirium and melatonin levels in elderly patients. Am J Surg 2001, 182:449–454.
Robinson T, Raeburn C, Angles E, Moss M: Low tryptophan levels are associated with postoperative delirium in the elderly. Am J Surg 2008, 196:670–674.
Carr R, Shrewsbury K: Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry 2007, 164:1020–1027.
Breitbart W, Alici Y: Agitation and delirium at the end of life. JAMA 2008, 200:2898–2910.
Rooij S, Schuurmans M, Van Der Mast R, Levi M: Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry 2005, 20:609–615.
Pandharipande P, Cotton B, Shintani A, et al.: Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007, 33:1726–1731.
Meagher D, Trzepacz P: Motoric subtypes of delirium. Sem Clin Neuropsychiatry 2000, 5:75–85.
Fick D, Agostini J, Inouye S: Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 2002, 50:1723–1732.
Bourgeois JA, Seritan A: Diagnosis and management of delirium. Continuum 2006, 12:15–32.
Lonergan E, Britton AM, Luxenberg J: Antipsychotics for delirium. Cochrane Database Syst Rev 2007:CD005594.
Alici-Evcimen Y, Breitbart W: An update on the use of antipsychotics in the treatment of delirium. Palliat Support Care 2008, 6:177–182.
Straker D, Shapiro P, Muskin P: Aripiprazole in the treatment of delirium. Psychosomatics 2006, 47:385–391.
Rochon PA, Normand SL, Gomes T, et al.: Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008, 168:1090–1096.
Arciniegas DB, McAllister TW: Neurobehavioral management of traumatic brain injury in the critical care setting. Crit Care Clin 2008, 24:737–765.
Rooij SE, van Munster BC, Korevaar JC, Levi M: Cytokines and acute phase response in delirium. J Psychosom Res 2007, 62:521–525.
Savaskan E, Schnitziear C, Schroeder C, et al.: Treatment of behavioral, cognitive, and circadian rest-activity cycle disturbances in Alzheimer’s disease: haloperidol vs. quetiapine. Int J Neuropsychopharmacol 2006, 9:507–516.
Grunze HCR: The effectiveness of anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci 2008, 10:77–84.
Bourgeois JA, Koike AK, Simmons JE, et al.: Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases. J Neuropsychiatry Clin Neurosci 2005, 17:232–238.
Overshott R, Karim S, Burns A: Cholinesterase inhibitors for delirium. Cochrane Database Syst Rev 2008: CD005317.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, R.A., Kahn, D. & Bourgeois, J.A. Delirium: Sifting through the confusion. Curr Psychiatry Rep 11, 226–234 (2009). https://doi.org/10.1007/s11920-009-0035-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-009-0035-8